Vindesine
"Vindesine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vinblastine derivative with antineoplastic activity against CANCER. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS).
| Descriptor ID |
D014751
|
| MeSH Number(s) |
D03.132.436.681.827.830 D03.438.473.402.681.827.830
|
| Concept/Terms |
Vindesine- Vindesine
- Vindesin
- Desacetylvinblastine Amide
Eldisine- Eldisine
- Enison
- EG Labo Brand of Vindesine Sulfate
- Lilly Brand of Vindesine Sulfate
|
Below are MeSH descriptors whose meaning is more general than "Vindesine".
Below are MeSH descriptors whose meaning is more specific than "Vindesine".
This graph shows the total number of publications written about "Vindesine" by people in this website by year, and whether "Vindesine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1982 | 0 | 1 | 1 |
| 1983 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vindesine" by people in Profiles.
-
Fuks JZ, Egorin MJ, Aisner J, Van Echo DA, Ostrow S, Bachur NR, Wiernik PH. Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma. Cancer Chemother Pharmacol. 1983; 10(2):104-8.
-
Fuks JZ, Aisner J, Carney DN, Van Echo DA, Ostrow SS, Ihde DC, Wiernik PH. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung. Am J Clin Oncol. 1982 Feb; 5(1):49-52.